(Q53961036)
Statements
Phase I trial of a ligand fusion-protein (DAB389IL-2) in lymphomas expressing the receptor for interleukin-2 (English)
C F LeMaistre
M N Saleh
T M Kuzel
F Foss
L C Platanias
G Schwartz
A Rook
C O Freytes
F Craig
J Reuben